Medicare EPO Proposal Would Withdraw Or Limit Coverage For Certain Cancer Uses
This article was originally published in The Pink Sheet Daily
Executive Summary
National Medicare coverage analysis follows recent FDA advisory committee review.
You may also be interested in...
ASCO Updates ESA Treatment Guidelines
Recommendation made jointly with American Society of Hematology calls for maintaining hemoglobin levels above 10 g/dL.
ASCO Updates ESA Treatment Guidelines
Recommendation made jointly with American Society of Hematology calls for maintaining hemoglobin levels above 10 g/dL.
EPO Use OK In All But Eight Cancer Conditions, Medicare NCD Says
Final National Coverage Determination issued July 30 drops number of restricted uses of erythropoiesis-stimulating agents from the 13 listed in the draft NCD.